Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Scott B. Seibel is active.

Publication


Featured researches published by Scott B. Seibel.


Bioorganic & Medicinal Chemistry Letters | 1997

Cyclic homopentapeptides. 1. Analogs of tuberactinomycins and capreomycin with activity against vancomycin-resistant enterococci and Pasteurella

John P. Dirlam; A. M. Belton; N.C. Birsner; R. R. Brooks; Shang-Poa Chang; R.Y. Chandrasekaran; J. Clancy; Brian J. Cronin; B. P. Dirlam; Steven M. Finegan; S. A. Froshauer; A.E. Girard; Shigeru F. Hayashi; R.J. Howe; J. C. Kane; Barbara J. Kamicker; S. A. Kaufman; Nicole L. Kolosko; M. A. Lemay; Robert Gerald Linde; J.P. Lyssikatos; C.P. MacLelland; Thomas V. Magee; M. A. Massa; S. A. Miller; Martha L. Minich; David Austen Perry; J.W. Petitpas; C.P. Reese; Scott B. Seibel

Abstract A 6a-(3′,4′-dichlorophenylamino) analog of viomycin was uncovered by a high-throughput screen against the animal health pathogen Pasteurella haemolytica, and has served as a novel lead structure for our infectious disease programs. We report herein the synthesis and activity of analogs of tuberactinomycins and capreomycin that are active against Pasteurella spp., methicillin-resistant Staphylococcus aureus, and vancomycin-resistant enterococci. This paper describes the synthesis and activity of some C-6a-substituted analogs of tuberactinomycins and capreomycin, which are active against Pasteurella spp., methicillin-resistant Staphylococcus aureus, and vancomycin-resistant enterococci.


Bioorganic & Medicinal Chemistry Letters | 2008

Comparative structure–activity relationship studies of 1-(5-methylsulfonylpyrid-2-yl)-5-alkyl and (hetero)aryl triazoles and pyrazoles in canine COX inhibition

Subas M. Sakya; Andrei Shavnya; Hengmiao Cheng; Chao Li; Bryson Rast; Jin Li; David A. Koss; Burton H. Jaynes; Donald W. Mann; Carol F. Petras; Scott B. Seibel; Michelle L. Haven; Michael P. Lynch

Structure-activity relationship (SAR) studies of novel 5-alkyl and 5-aryl/heteroaryl substituted 1,2,4-triazoles are described. The in vitro activity is compared to the pyrazole class of compounds with analogous side chains to delineate the contribution of the triazole ring nitrogen in binding to the active site. Both series are quite potent and selective in the canine whole blood (CWB) COX-2 assay, suggesting the increased binding contribution of the hydrophobic side chains.


Bioorganic & Medicinal Chemistry Letters | 1997

Cyclic homopentapeptides 2. Synthetic modifications of viomycin

J.P. Lyssikatos; Shang-Poa Chang; J. Clancy; John P. Dirlam; Steven M. Finegan; A.E. Girard; Shigeru F. Hayashi; D.P. Larson; A.S. Lee; Robert Gerald Linde; C.P. MacLelland; J.W. Petitpas; Scott B. Seibel; C.B. Vu

Abstract This paper describes synthetic modifications of the C-19 position of tuberactinomycin B (viomycin) and related analogs. The in vitro antibacterial activity of selected analogs against Pasteurella multocida, Escherichia coli and methicillin-resistant Staphylococcus aureus is also discussed. Although C-19 arylation and thiolation did not improve antibacterial activity, C-19 benzyl carbamates, benzyl- and phenyl ureas were found to be more potent than the parent antibiotic.


Bioorganic & Medicinal Chemistry Letters | 2006

5-Heteroatom substituted pyrazoles as canine COX-2 inhibitors. Part 1: Structure-activity relationship studies of 5-alkylamino pyrazoles and discovery of a potent, selective, and orally active analog

Subas M. Sakya; Kristin Lundy DeMello; Martha L. Minich; Bryson Rast; Andrei Shavnya; Robert J. Rafka; David A. Koss; Hengmiao Cheng; Jin Li; Burton H. Jaynes; Carl Bernard Ziegler; Donald W. Mann; Carol F. Petras; Scott B. Seibel; Annette M. Silvia; David M. George; Lisa A. Lund; Suzanne H. St. Denis; Anne Hickman; Michelle L. Haven; Michael P. Lynch


Bioorganic & Medicinal Chemistry Letters | 2006

Synthesis and SAR of heteroaryl-phenyl-substituted pyrazole derivatives as highly selective and potent canine COX-2 inhibitors.

Hengmiao Cheng; Kristin Lundy DeMello; Jin Li; Subas M. Sakya; Kazuo Ando; Kiyoshi Kawamura; Tomoki Kato; Robert J. Rafka; Burton H. Jaynes; Carl Bernard Ziegler; Rod Stevens; Lisa A. Lund; Donald W. Mann; Carolyn Rose Kilroy; Michelle L. Haven; Erik L. Nimz; Jason K. Dutra; Chao Li; Martha L. Minich; Nicole L. Kolosko; Carol F. Petras; Annette M. Silvia; Scott B. Seibel


Bioorganic & Medicinal Chemistry Letters | 2004

Discovery of a potent, selective and orally active canine COX-2 inhibitor, 2-(3-difluoromethyl-5-phenyl-pyrazol-1-yl)-5-methanesulfonyl-pyridine.

Jin Li; Kristin Lundy DeMello; Henry Cheng; Subas M. Sakya; Brian Scott Bronk; Robert J. Rafka; Burton H. Jaynes; Carl Bernard Ziegler; Carolyn Rose Kilroy; Donald W. Mann; Eric L. Nimz; Michael P. Lynch; Michelle L. Haven; Nicole L. Kolosko; Martha L. Minich; Chao Li; Jason K. Dutra; Bryson Rast; Rhonda Marie Crosson; Barry James Morton; Glen W. Kirk; Kathleen M. Callaghan; David A. Koss; Andrei Shavnya; Lisa A. Lund; Scott B. Seibel; Carol F. Petras; Annette M. Silvia


The Journal of Antibiotics | 1997

Structure-activity Relationships of Hygromycin A and Its Analogs: Protein Synthesis Inhibition Activity in a Cell Free System

Shigeru F. Hayashi; Laura J. L. Norcia; Scott B. Seibel; Annette M. Silvia


Bioorganic & Medicinal Chemistry Letters | 2007

5-Heteroatom substituted pyrazoles as canine COX-2 inhibitors. Part III: Molecular modeling studies on binding contribution of 1 -(5 -methylsulfonyl )pyrid -2 -yl and 4-nitrile

Subas M. Sakya; Xinjun Hou; Martha L. Minich; Bryson Rast; Andrei Shavnya; Kristin Lundy DeMello; Hengmiao Cheng; Jin Li; Burton H. Jaynes; Donald W. Mann; Carol F. Petras; Scott B. Seibel; Michelle L. Haven


Bioorganic & Medicinal Chemistry Letters | 2006

5-Heteroatom-substituted pyrazoles as canine COX-2 inhibitors: Part 2. Structure–activity relationship studies of 5-alkylethers and 5-thioethers

Subas M. Sakya; Hengmiao Cheng; Kristin Lundy DeMello; Andrei Shavnya; Martha L. Minich; Bryson Rast; Jason K. Dutra; Chao Li; Robert J. Rafka; David A. Koss; Jin Li; Burton H. Jaynes; Carl Bernard Ziegler; Donald W. Mann; Carol F. Petras; Scott B. Seibel; Annette M. Silvia; David M. George; Anne Hickman; Michelle L. Haven; Michael P. Lynch


The Journal of Antibiotics | 1998

In Vitro Microbiological Characterization of Novel Macrolide CP-163, 505 for Animal Health Specific Use

Laura J. L. Norcia; Scott B. Seibel; Barbara J. Kamicker; Mary A. Lemay; Susan C. Lilley; Scott J. Hecker; Jay Bergeron; James A. Retsema; Shigeru F. Hayashi

Collaboration


Dive into the Scott B. Seibel's collaboration.

Researchain Logo
Decentralizing Knowledge